New Publication

SynAI: An AI-driven Cancer Drugs Synergism Prediction Platform

Kuan Yan, Runjun Jia and Sheng Guo

Introducing SynAI, our state-of-the-art AI tool that swiftly and effectively predicts drug synergism in cancer cell lines, unlocking new potential in cancer treatment. Move beyond the time-intensive and cumbersome traditional methods of drug combination screening. SynAI leverages compound SMILE sequences to rapidly identify potential therapeutic combinations, significantly saving costs and enhancing research efficiency. Breaking free from the constraints of predefined compounds and cell lines, it offers a flexible and scalable solution that evolves with continuous research and data updates.

Download our paper to discover the advantages SynAI brings to your research.